Video Category

← FOG2022 Highlights

Drugging the cancer genome: progress, opportunities and challenges in personalised medicine

Drugging the cancer genome: progress, opportunities and challenges in personalised medicine

Paul Workman, Professor of Pharmacology and Therapeutics, Institute of Cancer Research

Molecular diagnostics and the NHSE Long Term Plan for Cancer

Molecular diagnostics and the NHSE Long Term Plan for Cancer

Peter Johnson, National Clinical Director for Cancer, NHS England

Liquid biopsy: From discovery to clinical implementation

Liquid biopsy: From discovery to clinical implementation

Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf

Cancer evolution, immune evasion and metastasis

Cancer evolution, immune evasion and metastasis

Charles Swanton, Senior Group Leader, Crick Institute

Translating germline cancer genomics into precision prevention of cancer

Translating germline cancer genomics into precision prevention of cancer

Clare Turnbull, Professor of Translational Cancer Genetics, Institute of Cancer Research